Franklin Templeton Group of Funds > Franklin Templeton ETF Trust
Franklin Genomic Advancements ETF
$9.89M
Avg Monthly Net Assets
$9.51M
Total Assets
$4K
Total Liabilities
$9.51M
Net Assets
Franklin Genomic Advancements ETF is an Exchange-Traded Fund in Franklin Templeton ETF Trust
from Franklin Templeton Group of Funds,
based in California,
United States of America.
The fund has one share class
and monthly net assets of $9.89M.
On August 26th, 2024 it reported 59 holdings, the largest
being Medpace Holdings Inc (7.2%), Vertex Pharmaceuticals Inc (5.5%) and Regeneron Pharmaceuticals Inc (5.4%).
Data provided by Fincoded.
Share Classes
| Name | Class/Contract ID | Exchange | Ticker | Monthly Returns (2 years) |
|---|---|---|---|---|
| Franklin Genomic Advancements ETF | C000216720 | BATS | HELX |
Holdings
From latest NPORT-P, filed August 26th, 2024 for period ending June 30th, 2024.
Historic holdings data available from Fincoded.
| Name | Profile | Category | Country | Value $USD | # Shares | % of Fund |
|---|---|---|---|---|---|---|
| 4D Molecular Therapeutics Inc | Long | Equity-common | US | $105K | 5K | 1.11 |
| Agilent Technologies Inc | Long | Equity-common | US | $189K | 1K | 1.99 |
| Alexandria Real Estate Equities Inc | Long | Equity-common | US | $28K | 242 | 0.30 |
| Alnylam Pharmaceuticals Inc | Long | Equity-common | US | $157K | 646 | 1.65 |
| AstraZeneca PLC | Long | Equity-common | GB | $258K | 3K | 2.72 |
| Avantor Inc | Long | Equity-common | US | $41K | 2K | 0.43 |
| Avid Bioservices Inc | Long | Equity-common | US | $55K | 8K | 0.57 |
| Azenta Inc | Long | Equity-common | US | $100K | 2K | 1.05 |
| Bavarian Nordic A/S | Long | Equity-common | DK | $25K | 995 | 0.26 |
| Beam Therapeutics Inc | Long | Equity-common | US | $80K | 3K | 0.84 |
| Bio-Rad Laboratories Inc | Long | Equity-common | US | $41K | 150 | 0.43 |
| Bio-Techne Corp | Long | Equity-common | US | $90K | 1K | 0.94 |
| BioNTech SE | Long | Equity-common | DE | $125K | 2K | 1.32 |
| Bridgebio Pharma Inc | Long | Equity-common | US | $86K | 3K | 0.90 |
| Bristol-Myers Squibb Co | Long | Equity-common | US | $23K | 565 | 0.25 |
| Bruker Corp | Long | Equity-common | US | $228K | 4K | 2.40 |
| Cadence Design Systems Inc | Long | Equity-common | US | $223K | 726 | 2.35 |
| Charles River Laboratories International Inc | Long | Equity-common | US | $197K | 953 | 2.07 |
| Corteva Inc | Long | Equity-common | US | $200K | 4K | 2.10 |
| CRISPR Therapeutics AG | Long | Equity-common | CH | $70K | 1K | 0.74 |
| Danaher Corp | Long | Equity-common | US | $467K | 2K | 4.91 |
| Dynavax Technologies Corp | Long | Equity-common | US | $19K | 2K | 0.20 |
| Eli Lilly & Co | Long | Equity-common | US | $474K | 523 | 4.98 |
| Evotec SE | Long | Equity-common | DE | $9K | 911 | 0.09 |
| Exact Sciences Corp | Long | Equity-common | US | $102K | 2K | 1.07 |
| ICON PLC | Long | Equity-common | IE | $171K | 544 | 1.79 |
| Insmed Inc | Long | Equity-common | US | $184K | 3K | 1.93 |
| Intellia Therapeutics Inc | Long | Equity-common | US | $85K | 4K | 0.90 |
| Ionis Pharmaceuticals Inc | Long | Equity-common | US | $245K | 5K | 2.57 |
| IQVIA Holdings Inc | Long | Equity-common | US | $99K | 466 | 1.04 |
| Krystal Biotech Inc | Long | Equity-common | US | $426K | 2K | 4.48 |
| Labcorp Holdings Inc | Long | Equity-common | US | $89K | 436 | 0.93 |
| Ligand Pharmaceuticals Inc | Long | Equity-common | US | $68K | 805 | 0.71 |
| Lonza Group AG | Long | Equity-common | CH | $103K | 188 | 1.08 |
| Medpace Holdings Inc | Long | Equity-common | US | $685K | 2K | 7.21 |
| Moderna Inc | Long | Equity-common | US | $243K | 2K | 2.56 |
| Natera Inc | Long | Equity-common | US | $324K | 3K | 3.41 |
| Neurocrine Biosciences Inc | Long | Equity-common | US | $94K | 683 | 0.99 |
| Neurogene Inc | Long | Equity-common | US | $27K | 753 | 0.29 |
| Olink Holding AB | Long | Equity-common | SE | $12K | 480 | 0.13 |
| OMNIAB INC | Long | Equity-common | US | $0 | 240 | – |
| OMNIAB INC | Long | Equity-common | US | $0 | 240 | – |
| QIAGEN NV | Long | Equity-common | NL | $172K | 4K | 1.81 |
| Recursion Pharmaceuticals Inc | Long | Equity-common | US | $63K | 8K | 0.66 |
| Regeneron Pharmaceuticals Inc | Long | Equity-common | US | $509K | 484 | 5.35 |
| Repligen Corp | Long | Equity-common | US | $47K | 370 | 0.49 |
| Revvity Inc | Long | Equity-common | US | $126K | 1K | 1.33 |
| Rocket Pharmaceuticals Inc | Long | Equity-common | US | $177K | 8K | 1.86 |
| Samsung Biologics Co Ltd | Long | Equity-common | KR | $258K | 489 | 2.72 |
| Sarepta Therapeutics Inc | Long | Equity-common | US | $191K | 1K | 2.01 |
| Sartorius AG | Long | Equity-preferred | DE | $188K | 801 | 1.98 |
| Simulations Plus Inc | Long | Equity-common | US | $42K | 861 | 0.44 |
| Thermo Fisher Scientific Inc | Long | Equity-common | US | $441K | 798 | 4.64 |
| Twist Bioscience Corp | Long | Equity-common | US | $128K | 3K | 1.34 |
| Ultragenyx Pharmaceutical Inc | Long | Equity-common | US | $84K | 2K | 0.89 |
| United Therapeutics Corp | Long | Equity-common | US | $153K | 480 | 1.61 |
| Veracyte Inc | Long | Equity-common | US | $15K | 687 | 0.16 |
| Vertex Pharmaceuticals Inc | Long | Equity-common | US | $525K | 1K | 5.53 |
| Voyager Therapeutics Inc | Long | Equity-common | US | $106K | 13K | 1.11 |
Address
Franklin Templeton ETF Trust
ONE FRANKLIN PARKWAY
SAN MATEO
California
94403
United States of America
Websites
Directors
Anantha K. Pradeep
Deborah D. McWhinney
Rohit Bhagat
Jennifer M. Johnson
Transfer Agents
State Street Bank and Trust Company
Pricing Services
S&P Global Inc.
Bloomberg L.P.
ICE Data Services, Inc.
PricingDirect Inc.
London Stock Exchange Group PLC
Standard & Poor's Financial Services LLC
Custodians
Citibank, National Association (Singapore, SG, Branch)
The Hongkong and Shanghai Banking Corporation Limited
Standard Chartered Bank (Hong Kong) Limited
State Street Bank and Trust Company
HSBC Bank (China) Company Limited
Euroclear Bank
Shareholder Servicing Agents
State Street Bank and Trust Company
Admins
State Street Bank and Trust Company
Franklin Templeton Services, LLC
Brokers
BofA Securities, Inc.
J.P. Morgan Securities LLC
Goldman Sachs & Co. LLC
Citigroup Global Markets Inc.
Morgan Stanley & Co. LLC
UBS Securities LLC